Other clinical studies on RNA–RNA interactions underlying the mechanism of breast cancer identified upregulation of human receptor tyrosine-protein kinase erbB-2 (ERBB2) by BCLIN25 through regulation of promoter CpG methylation on miR-125ERBB2 [96]. Here, ERBB2 is linked to breast carcinoma.